Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin.
Pediatr Nephrol. 2024 Jan;39(1):269-282. doi: 10.1007/s00467-023-06007-8. Epub 2023 Jun 26.
Pediatr Nephrol. 2024.
PMID: 37365422
At EV, pre-infusion biomarker concentrations had the highest area under the curves (AUC) (range: 0.61-0.62) for AKI diagnosis; at LV, biomarkers measured post-infusion and near discharge yielded the highest AUCs (range: 0.64-0.70). CONCLUSIONS: TIMP-2*IGFBP-7 were p …
At EV, pre-infusion biomarker concentrations had the highest area under the curves (AUC) (range: 0.61-0.62) for AKI diagnosis; at LV, …
Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer.
McMahon KR, Rassekh SR, Schultz KR, Blydt-Hansen T, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Palijan A, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Boyko D, Zappitelli M; Applying Biomarkers to Minimize Long-term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group.
McMahon KR, et al.
JAMA Netw Open. 2020 May 1;3(5):e203639. doi: 10.1001/jamanetworkopen.2020.3639.
JAMA Netw Open. 2020.
PMID: 32383745
Free PMC article.
Item in Clipboard
Tubular Injury Biomarkers to Predict Chronic Kidney Disease and Hypertension at 3-Months Post-Cisplatin in Children.
Huang RS, McMahon KR, Wang S, Chui H, Lebel A, Lee J, Cockovski V, Rassekh SR, Schultz KR, Blydt-Hansen TD, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Palijan A, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group*.
Huang RS, et al.
Kidney360. 2024 Apr 26. doi: 10.34067/KID.0000000000000448. Online ahead of print.
Kidney360. 2024.
PMID: 38668904
Free article.
BACKGROUND: Urine kidney injury biomarkers measured during cisplatin therapy may identify patients at risk for adverse subsequent kidney outcomes. ...METHODS: We analyzed data from the Applying Biomarkers to Minimize Long-Term Effects of …
BACKGROUND: Urine kidney injury biomarkers measured during cisplatin therapy may identify patients at risk for adverse subsequent kid …
Item in Clipboard
Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR, Lebel A, Rassekh SR, Schultz KR, Blydt-Hansen TD, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Palijan A, Lee J, Boyko D, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group.
McMahon KR, et al.
Pediatr Nephrol. 2023 May;38(5):1667-1685. doi: 10.1007/s00467-022-05745-5. Epub 2022 Oct 19.
Pediatr Nephrol. 2023.
PMID: 36260162
Item in Clipboard
Cite
Cite